EAM Investors’s Asensus Surgical, Inc. ASXC Stock Holding History

EAM Investors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-16,416	Closed	-$482K	–	336
2018 Q4	$482K	Sell	16,416 -418	-2%	-$19K	0.13%	241
2018 Q3	$1.27M	Sell	16,834 -2,074	-11%	-$140K	0.19%	187
2018 Q2	$1.07M	Buy	+18,908	New	+$689K	0.17%	196
2018 Q1	–	Sell	-24,984	Closed	-$627K	–	373
2017 Q4	$627K	Buy	+24,984	New	+$769K	0.11%	268

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EAM Investors's ASXC Position: Q1 2019 in Review

EAM Investors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2019, closing a stake of 16,416 shares — an estimated $482K sold.

EAM Investors first reported a position in ASXC in Q4 2017 and held it in 4 quarters. The position peaked at $1.27M in Q3 2018. 149 funds tracked by Wall St. Rank hold ASXC as of Q1 2019.

EAM Investors reported no remaining Asensus Surgical, Inc. position as of Q1 2019 after selling out during the quarter.
EAM Investors sold 16,416 Asensus Surgical, Inc. shares in Q1 2019, an estimated $482K.
EAM Investors first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 4 quarters.
EAM Investors's Asensus Surgical, Inc. position peaked at $1.27M in Q3 2018.
149 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2019.

Based on EAM Investors's 13F filing for Q1 2019, filed 13 May 2019.